Brenton K. Ahrens - Dec 23, 2022 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Brenton K. Ahrens
Stock symbol
ITRM
Transactions as of
Dec 23, 2022
Transactions value $
$23,591
Form type
4
Date filed
12/28/2022, 08:00 PM
Previous filing
Sep 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $23.6K +29.1K $0.81 29.1K Dec 23, 2022 Ordinary Shares 29.1K $0.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on October 1, 2023.